{"id":341328,"date":"2026-11-06T10:27:50","date_gmt":"2026-11-06T04:57:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=341328"},"modified":"2026-11-06T10:27:50","modified_gmt":"2026-11-06T04:57:50","slug":"gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/","title":{"rendered":"Gland Pharma Share Price: 27.7% CAGR in 3 Years as This Injectables Specialist Takes On Sun Pharma, Cipla and Lupin"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Gland_Pharma_Share_Price_277_CAGR_in_3_Years_as_This_Injectables_Specialist_Takes_On_Sun_Pharma_Cipla_and_Lupin\" title=\"Gland Pharma Share Price: 27.7% CAGR in 3 Years as This Injectables Specialist Takes On Sun Pharma, Cipla and Lupin\">Gland Pharma Share Price: 27.7% CAGR in 3 Years as This Injectables Specialist Takes On Sun Pharma, Cipla and Lupin<\/a><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#How_Much_Has_the_Gland_Pharma_Share_Price_Returned_in_3_Years\" title=\"How Much Has the Gland Pharma Share Price Returned in 3 Years?\">How Much Has the Gland Pharma Share Price Returned in 3 Years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Gland_Pharma_vs_Sun_Pharmaceutical_Industries_Cipla_and_Lupin_3-Year_CAGR_Compared\" title=\"Gland Pharma vs Sun Pharmaceutical Industries, Cipla and Lupin: 3-Year CAGR Compared\">Gland Pharma vs Sun Pharmaceutical Industries, Cipla and Lupin: 3-Year CAGR Compared<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Valuation_and_Quality_Compared\" title=\"Valuation and Quality Compared\">Valuation and Quality Compared<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#What_Is_Driving_the_Gland_Pharma_Stock\" title=\"What Is Driving the Gland Pharma Stock?\">What Is Driving the Gland Pharma Stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#How_the_Established_Players_Stack_Up\" title=\"How the Established Players Stack Up\">How the Established Players Stack Up<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#What_Should_Investors_Track_Next\" title=\"What Should Investors Track Next?\">What Should Investors Track Next?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#How_to_Compare_Pharma_Stocks_Yourself\" title=\"How to Compare Pharma Stocks Yourself\">How to Compare Pharma Stocks Yourself<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#A_Focused_Injectables_Maker_Ahead_of_the_Sector_Leaders\" title=\"A Focused Injectables Maker Ahead of the Sector Leaders\">A Focused Injectables Maker Ahead of the Sector Leaders<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#What_is_the_Gland_Pharma_share_price_today\" title=\"What is the Gland Pharma share price today?\">What is the Gland Pharma share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#What_is_the_3-year_CAGR_of_the_Gland_Pharma_stock\" title=\"What is the 3-year CAGR of the Gland Pharma stock?\">What is the 3-year CAGR of the Gland Pharma stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Is_Gland_Pharma_better_than_Sun_Pharma\" title=\"Is Gland Pharma better than Sun Pharma?\">Is Gland Pharma better than Sun Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#What_does_Gland_Pharma_do\" title=\"What does Gland Pharma do?\">What does Gland Pharma do?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Is_the_Gland_Pharma_stock_debt_free\" title=\"Is the Gland Pharma stock debt free?\">Is the Gland Pharma stock debt free?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Is_Gland_Pharma_expensive_compared_with_the_industry\" title=\"Is Gland Pharma expensive compared with the industry?\">Is Gland Pharma expensive compared with the industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#Which_pharma_stock_gave_the_highest_return_in_3_years\" title=\"Which pharma stock gave the highest return in 3 years?\">Which pharma stock gave the highest return in 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-3-year-cagr-vs-pharma-majors-sun-cipla-lupin\/#How_do_I_calculate_CAGR_for_a_stock\" title=\"How do I calculate CAGR for a stock?\">How do I calculate CAGR for a stock?<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h1><span class=\"ez-toc-section\" id=\"Gland_Pharma_Share_Price_277_CAGR_in_3_Years_as_This_Injectables_Specialist_Takes_On_Sun_Pharma_Cipla_and_Lupin\"><\/span><strong>Gland Pharma Share Price: 27.7% CAGR in 3 Years as This Injectables Specialist Takes On Sun Pharma, Cipla and Lupin<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h1>\n<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Gland Pharma previous close Rs 3,145.20. 3-year CAGR 27.7%. Up 2.1x since 3 Nov 2023. ROE 9.92%. Market cap Rs 51,934 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The <strong>Gland Pharma share price<\/strong> closed at Rs 3,145.20 on 5 November 2026, a compounded annual return of 27.7% over three years. That compares with Sun Pharmaceutical Industries at 17.0%, Cipla at 5.2% and Lupin at 18.8%. The company has a market cap of Rs 51,934 crore and a P\/E of 46.01 against an industry P\/E of 38.43.<\/p>\n<\/p><\/div>\n<p>The <strong>Gland Pharma share price<\/strong> offers a useful comparison between a focused sterile injectables company and the large diversified pharma names that dominate the sector. Gland Pharma, a Hyderabad-based maker of generic injectables that listed in late 2020, has compounded faster than three well-known pharma leaders over the last three years.<\/p>\n<p>This article puts numbers on that gap. We calculate the three-year CAGR for Gland Pharma, Sun Pharmaceutical Industries, Cipla and Lupin, and place the results beside market cap, valuation, return on equity and debt, using prices adjusted for corporate actions.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=gland-pharma-share-price\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Much_Has_the_Gland_Pharma_Share_Price_Returned_in_3_Years\"><\/span><strong>How Much Has the Gland Pharma Share Price Returned in 3 Years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Gland Pharma stock closed at Rs 1,510.50 on 3 November 2023 and at Rs 3,145.20 on 5 November 2026. Rs 1 lakh invested three years ago would have grown to about Rs 2.08 lakh, which is a CAGR of 27.7%. This is a price return and leaves out dividends.<\/p>\n<p>CAGR condenses a bumpy three-year ride into one yearly number, which is why it is the fairest way to compare companies of different sizes. A stock such as Gland Pharma can look spectacular on a chart and still have earned a modest yearly return, so the compounded figure keeps the comparison honest.<\/p>\n<p>The <strong>Gland Pharma share price<\/strong> has also been shaped by steady demand for complex injectables in regulated markets such as the United States and Europe, where supply gaps and approvals can matter for revenue.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Gland_Pharma_vs_Sun_Pharmaceutical_Industries_Cipla_and_Lupin_3-Year_CAGR_Compared\"><\/span><strong>Gland Pharma vs Sun Pharmaceutical Industries, Cipla and Lupin: 3-Year CAGR Compared<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table ranks the companies by three-year CAGR. Prices on 3 November 2023 are adjusted for splits and bonuses, and the latest figures are the previous close on 5 November 2026.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:14px 0;\">\n<tr>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Close on 3 Nov 2023<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Previous close (5 Nov 2026)<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Price multiple<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">3-year CAGR<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Gland Pharma<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,510.50<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 3,145.20<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">2.1x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">27.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Lupin<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,186.55<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,988.00<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.7x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">18.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Sun Pharmaceutical Industries<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,141.10<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,829.00<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.6x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">17.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Cipla<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,206.35<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,404.10<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.2x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">5.2%<\/td>\n<\/tr>\n<\/table>\n<p>The Gland Pharma stock leads the group at 27.7%, followed by Lupin at 18.8%, Sun Pharmaceutical Industries at 17.0% and Cipla at 5.2%. Gland leads the group, with Lupin second, followed by Sun Pharma and Cipla. The three peers are much larger by market cap, so their lower percentage returns came on a far bigger base.<\/p>\n<p>Look at the <strong>Gland Pharma share price<\/strong> alongside the peers as a snapshot of the last three years. It describes what happened, and valuation and earnings will decide what happens next.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_and_Quality_Compared\"><\/span><strong>Valuation and Quality Compared<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:14px 0;\">\n<tr>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Market cap<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Debt to equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 4,37,963 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">39.86<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">38.43<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">13.79%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla<\/a><\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,13,243 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">39.68<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">38.43<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">8.18%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\"><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin<\/a><\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 90,887 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">17.41<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">38.43<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">21.65%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Gland Pharma<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 51,934 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">46.01<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">38.43<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">9.92%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.03<\/td>\n<\/tr>\n<\/table>\n<p>By market cap, Sun Pharmaceutical Industries is the largest of the group at Rs 4,37,963 crore, while the Gland Pharma stock stands at Rs 51,934 crore, about 12% of that size. On earnings, Gland Pharma shares trade at a P\/E of 46.01 against an industry P\/E of 38.43, a premium of about 20%, which signals that the market expects faster earnings growth. Peer multiples are Sun Pharmaceutical Industries at 39.86, Cipla at 39.68 and Lupin at 17.41.<\/p>\n<p>Return on equity is 9.92% for the Gland Pharma stock, which ranks third among the four, and debt to equity stands at 0.03. Trailing EPS is Rs 68.41. Specialist injectable makers often trade at a premium multiple to the sector, so the P\/E is best read together with ROE and the pace of earnings growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Driving_the_Gland_Pharma_Stock\"><\/span><strong>What Is Driving the Gland Pharma Stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma develops and manufactures sterile injectables, including vials, ampoules, pre-filled syringes and ophthalmic products. It sells to partners in regulated markets and also markets its own products in several countries.<\/p>\n<p>Injectables are harder to make than tablets because of sterility requirements and regulatory scrutiny. That creates entry barriers, and a company with reliable plants and a strong filing pipeline can benefit from limited competition.<\/p>\n<p>Followers of the <strong>Gland Pharma share price<\/strong> usually track new product launches, regulatory inspection outcomes at its plants, the share of contract manufacturing in revenue and margins in the United States.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_the_Established_Players_Stack_Up\"><\/span><strong>How the Established Players Stack Up<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is India&#8217;s largest pharma company by market cap, with a presence in generics, specialty and branded products. It compounded at 17.0% a year, on a market cap of Rs 4,37,963 crore and an ROE of 13.79%.<\/p>\n<p>Cipla is a diversified pharma company with strong respiratory and global generics franchises. It compounded at 5.2% a year, on a market cap of Rs 1,13,243 crore and an ROE of 8.18%.<\/p>\n<p>Lupin is a global pharma company with a wide portfolio across generics, branded products and complex formulations. It compounded at 18.8% a year, on a market cap of Rs 90,887 crore and an ROE of 21.65%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Track_Next\"><\/span><strong>What Should Investors Track Next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Three things are worth watching on the <strong>Gland Pharma share price<\/strong>. First, the outcome of regulatory inspections at its manufacturing sites. Second, the pace of new injectable launches. Third, pricing trends in the United States, its largest export market.<\/p>\n<p>At a P\/E of 46, the stock trades above the industry multiple of 38, so earnings delivery matters. A three-year CAGR describes the past, so size any position with that in mind.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live fundamentals of pharma stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Compare_Pharma_Stocks_Yourself\"><\/span><strong>How to Compare Pharma Stocks Yourself<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>You can repeat this exercise for any pair of stocks, including the Gland Pharma stock against its peers. Note the adjusted closing price on the base date, take the latest close, divide one by the other, raise the result to the power of one third and subtract one. Then place the CAGR next to market cap, P\/E against the industry P\/E, ROE and debt to equity. Benchmark the result against the <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> as well, so you know whether the stock beat the broader market.<\/p>\n<p>A stock that scores well on growth but weakly on quality, or the reverse, deserves closer study before it enters a portfolio. When tracking the <strong>Gland Pharma share price<\/strong>, the same four checks give a more complete picture than price alone.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the <strong>Gland Pharma share price<\/strong> and compare pharma stocks live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"A_Focused_Injectables_Maker_Ahead_of_the_Sector_Leaders\"><\/span><strong>A Focused Injectables Maker Ahead of the Sector Leaders<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Gland Pharma share price<\/strong> compounded at 27.7% a year over three years, ahead of Lupin at 18.8%, Sun Pharma at 17.0% and Cipla at 5.2%.<\/p>\n<p>Sun Pharma and Cipla bring scale and diversification, Lupin brings the highest ROE among the peers at 21.65%, and Gland brings a specialist injectables play. Matching the choice to your risk appetite matters more than a single number.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Gland_Pharma_share_price_today\"><\/span><strong>What is the Gland Pharma share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma closed at Rs 3,145.20 on 5 November 2026, according to NSE data. It has a market cap of Rs 51,934 crore and a P\/E of 46.01. Check live quotes before acting, as prices change every trading day.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_3-year_CAGR_of_the_Gland_Pharma_stock\"><\/span><strong>What is the 3-year CAGR of the Gland Pharma stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma delivered a price CAGR of 27.7% over three years, moving from Rs 1,510.50 on 3 November 2023 to Rs 3,145.20 on 5 November 2026. The figure excludes dividends and uses adjusted closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Gland_Pharma_better_than_Sun_Pharma\"><\/span><strong>Is Gland Pharma better than Sun Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Gland stock delivered a higher three-year CAGR at 27.7% than Sun Pharma at 17.0%. Sun Pharma is far larger at Rs 4,37,963 crore and has a higher ROE of 13.79% against 9.92%, with a lower P\/E of 39.86. Better depends on whether you prefer growth or scale.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Gland_Pharma_do\"><\/span><strong>What does Gland Pharma do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma is a Hyderabad-based maker of sterile injectables, including vials, ampoules, pre-filled syringes and ophthalmic products, sold to partners and in its own name.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_Gland_Pharma_stock_debt_free\"><\/span><strong>Is the Gland Pharma stock debt free?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The debt to equity ratio of the Gland Pharma stock is 0.03 and its return on equity is 9.92%. Always check the latest balance sheet for current figures, as debt levels change with expansion plans.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Gland_Pharma_expensive_compared_with_the_industry\"><\/span><strong>Is Gland Pharma expensive compared with the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma trades at a P\/E of 46.01 against an industry P\/E of 38.43. A higher multiple reflects expectations of faster growth, which the company must deliver through earnings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_pharma_stock_gave_the_highest_return_in_3_years\"><\/span><strong>Which pharma stock gave the highest return in 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Among the companies compared here, Gland Pharma delivered the highest three-year CAGR at 27.7%, followed by Lupin at 18.8%. Past returns do not guarantee future performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_I_calculate_CAGR_for_a_stock\"><\/span><strong>How do I calculate CAGR for a stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divide the latest price by the starting price, raise the result to the power of one divided by the number of years, and subtract one. Multiply by 100 for a percentage. Use split and bonus adjusted prices for accurate results.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Gland Pharma share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma closed at Rs 3,145.20 on 5 November 2026, according to NSE data. It has a market cap of Rs 51,934 crore and a P\/E of 46.01. Check live quotes before acting, as prices change every trading day.\"}},{\"@type\":\"Question\",\"name\":\"What is the 3-year CAGR of the Gland Pharma stock?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma delivered a price CAGR of 27.7% over three years, moving from Rs 1,510.50 on 3 November 2023 to Rs 3,145.20 on 5 November 2026. The figure excludes dividends and uses adjusted closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Is Gland Pharma better than Sun Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Gland stock delivered a higher three-year CAGR at 27.7% than Sun Pharma at 17.0%. Sun Pharma is far larger at Rs 4,37,963 crore and has a higher ROE of 13.79% against 9.92%, with a lower P\/E of 39.86. Better depends on whether you prefer growth or scale.\"}},{\"@type\":\"Question\",\"name\":\"What does Gland Pharma do?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma is a Hyderabad-based maker of sterile injectables, including vials, ampoules, pre-filled syringes and ophthalmic products, sold to partners and in its own name.\"}},{\"@type\":\"Question\",\"name\":\"Is the Gland Pharma stock debt free?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The debt to equity ratio of the Gland Pharma stock is 0.03 and its return on equity is 9.92%. Always check the latest balance sheet for current figures, as debt levels change with expansion plans.\"}},{\"@type\":\"Question\",\"name\":\"Is Gland Pharma expensive compared with the industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma trades at a P\/E of 46.01 against an industry P\/E of 38.43. A higher multiple reflects expectations of faster growth, which the company must deliver through earnings.\"}},{\"@type\":\"Question\",\"name\":\"Which pharma stock gave the highest return in 3 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Among the companies compared here, Gland Pharma delivered the highest three-year CAGR at 27.7%, followed by Lupin at 18.8%. Past returns do not guarantee future performance.\"}},{\"@type\":\"Question\",\"name\":\"How do I calculate CAGR for a stock?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divide the latest price by the starting price, raise the result to the power of one divided by the number of years, and subtract one. Multiply by 100 for a percentage. Use split and bonus adjusted prices for accurate results.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Gland Pharma share price compounded at 27.7% a year over 3 years. See how it compares with Sun Pharma, Cipla and Lupin on returns, valuation and ROE.<\/p>\n","protected":false},"author":38,"featured_media":341327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[20837,20838,20839,19413],"class_list":["post-341328","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-gland-pharma-share-price","tag-gland-pharma-vs-sun-pharma","tag-injectable-pharma-stocks-india","tag-pharma-stocks-3-year-return"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["341327"],"rank_math_title":["Gland Pharma Share Price: 27.7% CAGR vs Sun, Cipla, Lupin"],"rank_math_description":["Gland Pharma share price compounded at 27.7% a year over 3 years. See how it compares with Sun Pharma, Cipla and Lupin on returns, valuation and ROE."],"rank_math_focus_keyword":["Gland Pharma share price | Density Target: 1.2-1.5%"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/gland-pharma-share-price-27-7-cagr-in-3-years-as-this-injectables-specialist.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/341328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=341328"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/341328\/revisions"}],"predecessor-version":[{"id":341329,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/341328\/revisions\/341329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/341327"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=341328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=341328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=341328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}